Niagen Bioscience, Inc. (NAGE) SEC Filings — 2025
12 SEC filings for Niagen Bioscience, Inc. (NAGE) in 2025.
Filings
- Niagen Bioscience, Inc. Files 8-K for Material Agreement — 8-K · Dec 22, 2025
- Niagen Bioscience Files 8-K — 8-K · Nov 6, 2025
- Niagen Bioscience Q3 Sales Soar 33%, Net Income Jumps 144% — 10-Q · Nov 4, 2025
- Niagen Bioscience Files 8-K — 8-K · Oct 6, 2025
- Niagen Bioscience 10-Q Lacks Key Financials, Equity Stagnant — 10-Q · Aug 6, 2025
- Niagen Bioscience Files 8-K for Material Agreement — 8-K · Jul 29, 2025
- Niagen Bioscience Reports Director/Officer Changes & Shareholder Votes — 8-K · Jun 27, 2025
- Niagen Bioscience Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Niagen Bioscience, Inc. DEF 14A Filing — DEF 14A · Apr 29, 2025
- Niagen Bioscience Changes Fiscal Year End — 8-K · Mar 19, 2025
- ChromaDex Corp. Files 2024 10-K — 10-K · Mar 4, 2025
- ChromaDex Corp. Names New Directors, Adjusts Executive Pay — 8-K · Feb 27, 2025